miR-19 Is a Potential Clinical Biomarker for Gastrointestinal Malignancy: A Systematic Review and Meta-analysis

Figure 9

Forest plot of hazard ratio (HR). Association between miR-19 expression and the OS of liver cancer (a), colorectal cancer (b), gastric cancer (c), and pancreatic cancer (d) patients.

(a)

(b)

(c)

(d)